| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |